Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 1;555(7694):121-125.
doi: 10.1038/nature25773. Epub 2018 Feb 21.

Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex

Affiliations

Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex

Yi-Lynn Liang et al. Nature. .

Abstract

The class B glucagon-like peptide-1 (GLP-1) G protein-coupled receptor is a major target for the treatment of type 2 diabetes and obesity. Endogenous and mimetic GLP-1 peptides exhibit biased agonism-a difference in functional selectivity-that may provide improved therapeutic outcomes. Here we describe the structure of the human GLP-1 receptor in complex with the G protein-biased peptide exendin-P5 and a Gαs heterotrimer, determined at a global resolution of 3.3 Å. At the extracellular surface, the organization of extracellular loop 3 and proximal transmembrane segments differs between our exendin-P5-bound structure and previous GLP-1-bound GLP-1 receptor structure. At the intracellular face, there was a six-degree difference in the angle of the Gαs-α5 helix engagement between structures, which was propagated across the G protein heterotrimer. In addition, the structures differed in the rate and extent of conformational reorganization of the Gαs protein. Our structure provides insights into the molecular basis of biased agonism.

PubMed Disclaimer

References

    1. Cell. 2016 Jun 16;165(7):1632-1643 - PubMed
    1. Nat Commun. 2016 Jan 28;7:10534 - PubMed
    1. Mol Endocrinol. 2011 Oct;25(10):1804-18 - PubMed
    1. Biosci Rep. 2015 Nov 23;36(1):e00285 - PubMed
    1. Biochem Pharmacol. 2017 Jul 15;136:99-108 - PubMed

Publication types

MeSH terms

Substances